279 related articles for article (PubMed ID: 15605412)
1. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2).
Albuisson J; Pêcheux C; Carel JC; Lacombe D; Leheup B; Lapuzina P; Bouchard P; Legius E; Matthijs G; Wasniewska M; Delpech M; Young J; Hardelin JP; Dodé C
Hum Mutat; 2005 Jan; 25(1):98-9. PubMed ID: 15605412
[TBL] [Abstract][Full Text] [Related]
2. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
Sato N; Katsumata N; Kagami M; Hasegawa T; Hori N; Kawakita S; Minowada S; Shimotsuka A; Shishiba Y; Yokozawa M; Yasuda T; Nagasaki K; Hasegawa D; Hasegawa Y; Tachibana K; Naiki Y; Horikawa R; Tanaka T; Ogata T
J Clin Endocrinol Metab; 2004 Mar; 89(3):1079-88. PubMed ID: 15001591
[TBL] [Abstract][Full Text] [Related]
3. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
Hardelin JP; Dodé C
Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
[TBL] [Abstract][Full Text] [Related]
4. [Molecular genetics of Kallmann syndrome: an update].
Fu C; Feng Z; Liu RZ
Zhonghua Nan Ke Xue; 2011 Apr; 17(4):361-5. PubMed ID: 21548217
[TBL] [Abstract][Full Text] [Related]
5. Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism.
Versiani BR; Trarbach E; Koenigkam-Santos M; Dos Santos AC; Elias LL; Moreira AC; Latronico AC; de Castro M
Clin Endocrinol (Oxf); 2007 Feb; 66(2):173-9. PubMed ID: 17223984
[TBL] [Abstract][Full Text] [Related]
6. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia.
Trarbach EB; Costa EM; Versiani B; de Castro M; Baptista MT; Garmes HM; de Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2006 Oct; 91(10):4006-12. PubMed ID: 16882753
[TBL] [Abstract][Full Text] [Related]
7. Kallmann's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations.
Salenave S; Chanson P; Bry H; Pugeat M; Cabrol S; Carel JC; Murat A; Lecomte P; Brailly S; Hardelin JP; Dodé C; Young J
J Clin Endocrinol Metab; 2008 Mar; 93(3):758-63. PubMed ID: 18160472
[TBL] [Abstract][Full Text] [Related]
8. Paediatric phenotype of Kallmann syndrome due to mutations of fibroblast growth factor receptor 1 (FGFR1).
Zenaty D; Bretones P; Lambe C; Guemas I; David M; Léger J; de Roux N
Mol Cell Endocrinol; 2006 Jul; 254-255():78-83. PubMed ID: 16757108
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
[TBL] [Abstract][Full Text] [Related]
10. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome.
Kim SH; Hu Y; Cadman S; Bouloux P
J Neuroendocrinol; 2008 Feb; 20(2):141-63. PubMed ID: 18034870
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of disease: Insights into X-linked and autosomal-dominant Kallmann syndrome.
Tsai PS; Gill JC
Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):160-71. PubMed ID: 16932275
[TBL] [Abstract][Full Text] [Related]
12. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome.
Dodé C; Levilliers J; Dupont JM; De Paepe A; Le Dû N; Soussi-Yanicostas N; Coimbra RS; Delmaghani S; Compain-Nouaille S; Baverel F; Pêcheux C; Le Tessier D; Cruaud C; Delpech M; Speleman F; Vermeulen S; Amalfitano A; Bachelot Y; Bouchard P; Cabrol S; Carel JC; Delemarre-van de Waal H; Goulet-Salmon B; Kottler ML; Richard O; Sanchez-Franco F; Saura R; Young J; Petit C; Hardelin JP
Nat Genet; 2003 Apr; 33(4):463-5. PubMed ID: 12627230
[TBL] [Abstract][Full Text] [Related]
13. Renal dysgenesis and KAL1 gene defects in patients with sporadic Kallmann syndrome.
Georgopoulos NA; Koika V; Galli-Tsinopoulou A; Spiliotis BE; Adonakis G; Keramida MK; Sgourou A; Koufogiannis KD; Papachatzopoulou A; Papavassiliou AG; Kourounis G; Vagenakis GA
Fertil Steril; 2007 Nov; 88(5):1311-7. PubMed ID: 17603054
[TBL] [Abstract][Full Text] [Related]
14. Kallmann syndrome.
Dodé C; Hardelin JP
Eur J Hum Genet; 2009 Feb; 17(2):139-46. PubMed ID: 18985070
[TBL] [Abstract][Full Text] [Related]
15. Kallmann syndrome: fibroblast growth factor signaling insufficiency?
Dodé C; Hardelin JP
J Mol Med (Berl); 2004 Nov; 82(11):725-34. PubMed ID: 15365636
[TBL] [Abstract][Full Text] [Related]
16. [Children with idiopathic hypogonadotropic hypogonadism: clinical data analysis and mutations analysis of KAL1 and FGFR1 gene].
Qin M; Gong C; Qi Z; Wu D; Liu M; Gu Y; Cao B; Li W; Liang X
Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):942-7. PubMed ID: 25619354
[TBL] [Abstract][Full Text] [Related]
17. Clinical genetics of Kallmann syndrome.
Dodé C; Hardelin JP
Ann Endocrinol (Paris); 2010 May; 71(3):149-57. PubMed ID: 20362962
[TBL] [Abstract][Full Text] [Related]
18. Kallmann syndrome in women: from genes to diagnosis and treatment.
Meczekalski B; Podfigurna-Stopa A; Smolarczyk R; Katulski K; Genazzani AR
Gynecol Endocrinol; 2013 Apr; 29(4):296-300. PubMed ID: 23368665
[TBL] [Abstract][Full Text] [Related]
19. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
Pitteloud N; Meysing A; Quinton R; Acierno JS; Dwyer AA; Plummer L; Fliers E; Boepple P; Hayes F; Seminara S; Hughes VA; Ma J; Bouloux P; Mohammadi M; Crowley WF
Mol Cell Endocrinol; 2006 Jul; 254-255():60-9. PubMed ID: 16764984
[TBL] [Abstract][Full Text] [Related]
20. Isolated gonadotropic deficiency with and without anosmia: a developmental defect or a neuroendocrine regulation abnormality of the gonadotropic axis.
de Roux N
Horm Res; 2005; 64 Suppl 2():48-55. PubMed ID: 16286771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
